A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer

INTRODUCTION: In this study, a structurally modified phosphoramidate scaffold, with improved prostate-specific membrane antigen (PSMA) avidity, stability and in vivo characteristics, as a PET imaging agent for prostate cancer (PCa), was prepared and evaluated. METHODS: p-Fluorobenzoyl-aminohexanoate...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nucl Med Biol
Main Authors: Ganguly, Tanushree, Dannoon, Shorouk, Hopkins, Mark R., Murphy, Stephanie, Cahaya, Hendry, Blecha, Joseph E., Jivan, Salma, Drake, Christopher R., Barinka, Cyril, Jones, Ella F., VanBrocklin, Henry F., Berkman, Clifford E.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4624265/
https://ncbi.nlm.nih.gov/pubmed/26169882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2015.06.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares